Objectives The Chronic Liver Disease Questionnaire (CLDQ) is a validated tool measuring Health Related Quality of Life among patients with cirrhosis. The aim of this study was to validate a Sinhala version of the CLDQ (sCLDQ) and to test its correlation with the degree of liver dysfunction in a cohort of Sri Lankan patients with cirrhosis.
Introduction
Health related quality of life (HRQL) is important in people with chronic diseases. Cirrhosis of the liver has a considerable effect on patients' physical and psychosocial wellbeing. The progression of symptoms, functional 14 . Salzman MB, Sharrar RG, Steinberg S, LaRussa P.
Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant mother. Conclusions CLDQ is a reliable and valid tool to assess quality of life of Sri Lankan patients with cirrhosis and correlates well with known indices of disease severity.
Several disease-specific symptoms such as pruritus, muscle cramps, sleep disturbance, sexual dysfunction, fatigue, and gastrointestinal symptoms have an effect on the QOL in patients with cirrhosis [1] . Knowledge of symptom profiles in chronic liver disease (CLD) may help in the development of more comprehensive treatment plans. Child-Turcotte-Pugh (CTP), model for end stage liver disease (MELD) and MELD-sodium (MELD-Na) are well known scoring systems of disease severity that depend on laboratory investigations, but do not measure QOL [2] [3] [4] . Assessment of HRQL is important for these patients in view of the paucity of therapies except for liver transplantation that substantially improve survival. Liver transplantation improves QOL but it is not yet wellestablished in Sri Lanka [5] [6] [7] [8] . Even in countries where it is available, there is a significant mismatch between demand and supply of organs.
The Chronic Liver Disease Questionnaire (CLDQ) developed by Younossi et al is the first liver specific questionnaire, designed to measure HRQL [9] . CLDQ is short and easy to administer, and is designed to measure six domains of QOL; abdominal symptoms, fatigue, systemic symptoms, activity, emotional functions and worry. All 29 items assess subjective symptoms over the previous 2 weeks on a 7 point Likert scale, with 1 corresponding to the maximum frequency ("all of the time") and 7 to the minimum ("none of the time"). Domain scores are derived from the means of the items in each domain and the overall score is the mean of all domains. CLDQ has been translated into different languages around the world and validated. It has shown good correlation with severity of liver disease [10] [11] [12] [13] [14] [15] . Despite the growing health burden associated with cirrhosis in Sri Lanka, there have been no attempts to evaluate QOL of patients with chromic liver disease (CLD). The aim of this study was to validate a Sinhala version of the CLDQ and to test its correlation with the degree of liver dysfunction in a cohort of Sri Lankan patients with cirrhosis.
Methods
This study was carried out in the Gastroenterology Clinic, University Medical Unit, Colombo North Teaching Hospital, Ragama. The study was carried out in two steps: translation of the Sinhala version of CLDQ (sCLDQ) and validation of the translated sCLDQ.
Translation of CLDQ to Sinhala
A standard method of translation introduced by the MAPI Research Institute was used for the translation of CLDQ to Sinhala (sCLDQ) [16, 17] . Definition of concepts of each item of the CLDQ and forward translation was carried out by two bilingual translators. A meeting was held to agree on the final version, and back translation of this version was performed by a third translator. After comparison of the original and the back translation by the interim investigators, pilot testing was carried out on 10 patients with stable CLD. Relevant adaptations were done according to differences in culture and language. The final translated version had optimal both linguistic and conceptual equivalence.
Validation of the sCLDQ
A cross sectional study was carried out to validate the sCLDQ in the outpatient clinic over a three month period. Patients with cirrhosis who spoke Sinhala and attending follow up clinics from December 2011 were recruited after obtaining informed written consent. Patients with clinically stable CLD of any aetiology between 18 and 70 years of age were included. Patients with other uncontrolled co-morbidities such as congestive heart failure, diabetes, hypertension with complications, end stage chronic kidney disease, stroke, active inflammatory bowel disease or malignancies were excluded. Patients who had hepatic encephalopathy grade 2 or worse, a hospital admission within the past two weeks, active psychological ailments or those who were illiterate were also excluded.
Of the 628 patients with cirrhosis in the data base, 214 were recruited for the final study. Relevant demographic, socioeconomic, clinical and biochemical information was obtained using an interviewer administered data extraction form. sCLDQ was self-administered. Of the 214 participants, WHOQOL-BREF was administered to 48 [18] . Following a period of 4 weeks, re-testing was done on 18 participants. WHOQOL-BREF contains four domains of QOL: physical, psychological, social and environments. It has been translated into several languages and validated. It has been used to assess QOL in a large number of different diseases around the world. In Sri Lanka, WHOQOL-BREF was validated in a cohort of patients with polycystic ovarian disease [19] .
Data Analysis
Data were analysed using SPSS statistical package version 21. Demographic and clinical characteristics were described for the total sample, WHOQOL-BREFF subsample and re-test sub-sample. Distribution of scores was described for the total score and domain scores by calculating mean, standard deviation, proportion of patients with a missing item, range, percentage of patients with worst (floor) and best (ceiling) scores.
Reliability was assessed using internal consistency and reproducibility. Internal consistency was evaluated with Cronbach's alpha co-efficient. Reproducibility was Papers evaluated with intra class correlation and test-retest scores. Intra-class correlation coefficient was calculated with a two-way-mixed and absolute agreement models. Test-retest correlation was assessed with Pearson's correlation co-efficient. A correlation co-efficient of 0 conformed to no agreement at all and 1 to full agreement.
Structural validity, the extent to which placement of items into domains agreed with the distribution of the original questionnaire was assessed using exploratory factor analysis with varimax rotation. Number of factors was determined with Monte-Carlo parallel analysis.
Construct validity, the extent to which sCLDQ scores demonstrated logical relations with other health related quality of life and clinical measures was assessed with correlation of sCLDQ score with WHOQOL-BREF score, MELD score, platelet count, serum sodium, bilirubin and albumin levels. Relationship with Child grade was assessed with one-way analysis of variance (ANOVA) and post hoc analysis was done using Tukey's test.
Approval to conduct the study was obtained from the Ethics Committee of the Faculty of Medicine, University of Kelaniya.
Results
A total of 214 patients with chronic liver disease [mean age 55.6 years (SD 10.4), 77.6% males] were recruited to validate the questionnaire. All were patients with cirrhosis either without any co-morbidities or with stable co-morbidities. Nearly half the patients had alcohol cirrhosis ( Table 1 ). The average duration of CLD was 2.5 years (SD 2.8) and most were Child A grade. From this total cohort, the WHOQOL-BREF questionnaire was administered to a sub-sample of 48 participants and a retest was carried out in 18 subjects. These sub-samples had an age-sex distribution corresponding with the total cohort. However, the majority of the WHOQOL-BREF sub-sample comprised of Child B grade. Cryptogenic/NASH cirrhosis was commoner in both sub-samples compared to the total cohort ( Table 1 ).
The total and domain score distributions for sCLDQ are summarized in Table 2 . The mean item scores ranged from 3.8 to 5.3. Only 35 (16.4%) patients needed assistance in completing the questionnaire. The questionnaire had good understandability with only 3 missing items (1.14%). Overall and domain scores ranged from 1 to 7. The overall floor and ceiling effects were minimal except for the domains of 'abdominal symptoms' and 'worry' which showed higher ceiling effects with 30 (14%) and 31 (14.6%) respectively. sCLDQ had an overall Cronbach's alpha of 0.926 and 4 out of 6 domains had cronbach's alpha values over 0.7. Overall intra-class correlation was 0.912 (p < 0.001) and test-retest correlation was 0.695 (p = 0.008). 'Systemic symptoms' and 'activity', the two domains with lower alpha values (0.607 and 0.484), showed significant intra-class correlation (r= 0.552 and 0.431 respectively, p = 0.000) and test-retest correlations (r= 0.755 and 0.784 respectively, p = 0.001). Though 'fatigue' didn't show a significant test-retest correlation (r= 0.430, p = 0.125) the Cronbach's alpha was 0.813. It had significant intra-class correlation (r= 0.808, p = 0.000). Monte-Carlo parallel analysis showed 8 domains as opposed to the 6 domains described in the original questionnaire. Exploratory factor analysis according to these eight domains is described in Sub-sample analysis of the WHOQOL-BREF questionnaire showed a small but significant positive correlation between sCLDQ scores and WHOQOL-BREF domains. Total and all sub-domain scores of sCLDQ except abdominal symptoms correlated significantly with "physical" and "psychological" sub-domains of WHO-BREF (r >0.2, p < 0.05). sCLDQ "Abdominal symptoms" correlated with the physical sub-domain of WHO BREF (r 0.297, p = 0.020). "Social" and "environmental" subdomains of WHO-BREF did not correlate significantly with total or sub-domain scores of sCLDQ. 
Table1. Demographic and clinical characteristics

Discussion
The Sinhala version of CLDQ could be easily selfadministered with minimal assistance and was well accepted by patients. The total and domain score distributions were similar to the original questionnaire and other translated versions. We found the sCLDQ to be a reliable and valid tool to assess QOL of Sinhala speaking Sri Lankan patients with cirrhosis. It correlated well with known indices of disease severity.
The overall internal consistency was excellent ). This could be due to lack of exact language constructs to differentiate these entities from each other.
The original CLDQ was re-tested after six months but we carried out the re-test after four weeks. A period of 4 weeks was selected as it was considered the best time duration to balance the inconsistencies due to progression of the disease and recall bias. Test-retest correlation showed moderate to high significant correlations, except in the 'fatigue' domain. This is probably due to items 4 and 13 relating to drowsiness, the removal of which increased the test-retest correlation of this domain significantly. This is further supported by identification of, 'drowsiness' as a separate domain. Poor test-retest correlation may be due to variability of a symptom like drowsiness over a period of 4 weeks. Despite these minor inconsistencies in test-retest correlations, overall and individual-domain intra-class correlations remained highly significant, thereby confirming the reliability of sCLDQ.
The original 6 domain structure of CLDQ was retained in the Sinhala version, with two additional domains. The 'worry' domain retained all of its items as in the original CLDQ. Items related to sleep disturbance (Items 16 and 20) which were listed under the 'emotional function' domain in the original CLDQ, appeared as a separate domain (poor sleep domain) while the rest of the elements of that domain remained together. Two out of three elements of the original 'activity' domain remained together, while item 9 loaded on the 'fatigue' domain. The elements which remained in the 'activity' domain were related to the diet, while item 9, regarding carrying heavy objects was considered a 'fatigable' activity rather than a simple day to day activity by to our cohort. Items 4 and 13 of the 'fatigue' domain appeared as a separate 'drowsiness' domain. In the 'systemic symptoms' domain, element 3 regarding bodily pain and element 6 regarding shortness of breath, correlated more with the 'fatigue' domain. This could probably be due to linguistic issues where the differentiation between these terms is blurred. sCLDQ total showed significant positive correlation with the physical and psychological domains of the WHOQOL-BREF questionnaire. It did not show significant correlation with social and environmental domains which may be because those aspects are only minimally addressed by the CLDQ. sCLDQ showed low but significant correlation with MELD score, MELD sodium score, serum sodium, albumin and bilirubin levels reflecting its construct validity. The significant difference of sCLDQ scores between Child B and C categories further con-firmed this.
In conclusion, even though there are some limitations, the Sinhala version of the CLDQ is a valid and reliable tool to assess the quality of life of Sinhala speaking patients with cirrhosis. This is important given the growing health burden associated with cirrhosis in Sri Lanka.
